期刊
NEUROLOGICAL SCIENCES
卷 31, 期 -, 页码 231-234出版社
SPRINGER
DOI: 10.1007/s10072-010-0367-5
关键词
Multiple sclerosis; Magnetic resonance imaging; Cognitive impairment; Gray matter; Cortical reorganization
资金
- Bayer Schering Pharma
- Biogen-Dompe AG
- Genmab A/S
- Merck Serono
- Teva Pharmaceutical Industries Ltd.
- Fondazione Italiana Sclerosi Multipla
- Fondazione Mariani
Magnetic resonance imaging (MRI) techniques have contributed to ameliorate the understanding of the mechanisms responsible for the accumulation of cognitive impairment in patients with multiple sclerosis. Earlier studies demonstrated a relationship of the location of T2-visible lesions in critical brain regions and atrophy of several brain compartments with the severity of cognitive impairment in these patients. More recently, the development of new postprocessing approaches and the application of quantitative MR techniques for the assessment of structural disease-related damage in the brain normal-appearing white matter and gray matter resulted in a better understanding of the factors associated with the onset and development of deficits of several cognitive domains. In addition, the use of functional MRI has disclosed that brain cortical reorganization may play a role in limiting the neuropsychological consequences of structural damage in the different stages of the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据